We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IVAI
651
Ives Ultra AI Opportunities
IVAI
$252M
$5.1M 0.02%
+500,000
New +$5.1M
2026 Q3
0 quarters
NWE icon
652
DELISTED
NorthWestern Energy
NWE
$5.1M 0.02%
74,560
-28,992
-28% -$2.04M
2025 Q4
3 quarters
IGACU icon
653
Invest Green Acquisition Corp Units
IGACU
$153M
$5.09M 0.02%
500,000
– –
2025 Q4
3 quarters
ADI icon
654
Analog Devices
ADI
$185B
$5.09M 0.02%
+12,818
New +$4.83M
2026 Q3
0 quarters
ETSS.U
655
Energy Transition Special Opportunities Units
ETSS.U
$5.08M 0.02%
500,000
– –
2026 Q2
1 quarter
HCICU icon
656
Hennessy Capital Investment VIII Units
HCICU
$5.06M 0.02%
500,000
– –
2026 Q1
2 quarters
BWIV.U icon
657
Blue Water Acquisition Corp IV Units
BWIV.U
$5.06M 0.02%
500,000
– –
2026 Q1
2 quarters
ITGR icon
658
Integer Holdings
ITGR
$5.05M 0.02%
+40,000
New +$4.64M
2026 Q3
0 quarters
ARTCU icon
659
Art Technology Acquisition Corp Units
ARTCU
$5.04M 0.02%
500,000
– –
2026 Q1
2 quarters
MZYX.U icon
660
MOZAYYX Acquisition Corp Units
MZYX.U
$314M
$5.04M 0.02%
500,000
– –
2026 Q1
2 quarters
FTHAU icon
661
Forefront Tech Holdings Acquisition Corp Unit
FTHAU
$105M
$5.04M 0.02%
500,000
– –
2026 Q2
1 quarter
RPRX icon
662
Royalty Pharma
RPRX
$30.6B
$5.03M 0.02%
+86,117
New +$5.08M
2026 Q3
0 quarters
PALOU icon
663
Paloma Acquisition Corp I Units
PALOU
$156M
$5.02M 0.02%
500,000
– –
2026 Q1
2 quarters
IPXG icon
664
Inflection Point Acquisition Corp VII
IPXG
$320M
$5.02M 0.02%
500,000
– –
2026 Q2
1 quarter
AMZN icon
665
CALL
Amazon
AMZN
$2.9T
$5.01M 0.02%
20,100
-34,900
-63% -$8.87M
2025 Q2
5 quarters
ATAT icon
666
Atour Lifestyle Holdings
ATAT
$5.33B
$5M 0.02%
153,427
-5,682
-4% -$190K
2026 Q1
2 quarters
ROK icon
667
Rockwell Automation
ROK
$43.4B
$5M 0.02%
11,481
+9,691
+541% +$4.31M
2026 Q1
2 quarters
V icon
668
Visa
V
$775B
$4.99M 0.02%
13,881
-10,232
-42% -$3.74M
2026 Q1
2 quarters
PACB icon
669
Pacific Biosciences
PACB
$571M
$4.97M 0.02%
+2,096,436
New +$2.96M
2026 Q3
0 quarters
BZH icon
670
DELISTED
Beazer Homes USA
BZH
$4.97M 0.02%
+148,977
New +$4.87M
2026 Q3
0 quarters
TAK icon
671
Takeda Pharmaceutical
TAK
$68B
$4.94M 0.02%
+271,713
New +$4.81M
2026 Q3
0 quarters
PTGX icon
672
Protagonist Therapeutics
PTGX
$8.3B
$4.93M 0.02%
35,000
-3,000
-8% -$428K
2025 Q4
3 quarters
SMMT icon
673
CALL
Summit Therapeutics
SMMT
$8.4B
$4.92M 0.02%
291,100
+191,000
+191% +$2.86M
2026 Q1
2 quarters
ASX icon
674
ASE Group
ASX
$71.8B
$4.9M 0.02%
+110,244
New +$4.32M
2026 Q3
0 quarters
CRDO icon
675
CALL
Credo Technology Group
CRDO
$23.1B
$4.87M 0.01%
+25,000
New +$5.38M
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.